LIFE'S parallels are endless-and the presence of women on stage is no exception. Consider this: in Shakespeare's London, men and adolescent boys played the role of female characters for literally decades. Paradoxically, they might even have found occasion to play the part of a woman pretending to be a man. Now there's talent! It was not until 1642, at the start of the English Civil War when the Puritans gained control, that stage plays were banned, and theaters and playhouses were shuttered. 1 With the restoration of the English monarchy (or should we call it "manarchy"?) in 1660, King Charles II, after having spent years in exile at the court of Louis XIV of France, had developed an appreciation for the theater arts. In addition to reinstituting the theater in England, Charles II allowed women to act professionally for the first time, having developed great enthusiasm for their talents on the French stage. 2 Most notably, Anne Marshall is credited with likely having been the first woman to play Desdemona in Othello in 1660, 44 years after Shakespeare's death. 1 Now, here we are in the 21st century's modern scientific world where presumably we have made great strides and yet men continue to grace the podium in far greater numbers than women, paralleling history on multiple levels.In this issue of the Journal of Cardiothoracic and Vascular Anesthesia, Shilcutt et al. examined the representation of women as speakers at the Society of Cardiovascular Anesthesiologists (SCA) annual meetings' scientific sessions over a 4year period (2015-2018). 3 These sessions included the main program, problem-based learning discussions (PBLDs), workshops, and moderation of fellow sessions. SCA membership by gender was estimated using the recent 2019 SCA Diversity Survey, which yielded a female representation of 29.1%. The authors found that for all combined sessions, there was an overall significant difference in the expected versus observed proportion of women speakers, who accounted for 22% to 25% of all speakers. However, further breakdown demonstrated that these differences remained significant for the main sessions but not the PBLDs, workshops, and fellow sessions.So, is this good news that women are being equitably represented at PBLDs, workshops, and fellow sessions? When you begin to think about it, not really. The prestige lies with the main program, including keynote addresses, plenary sessions, etc. It then should come as no surprise that women are underrepresented in the more coveted and esteemed portions of the program. As will be discussed further in the following, this problem is not unique to the SCA and has been described repeatedly in various medical and surgical specialties, technology, business, and other unrelated professions.